| Literature DB >> 26732390 |
Yingying Sun1, Na Li1, Jing Zhang2, Hongtao Liu1, Jianfang Liu1, Xiaojing Xia1, Changjiang Sun1, Xin Feng1, Jingmin Gu1, Chongtao Du1, Wenyu Han1, Liancheng Lei3.
Abstract
Streptococcus suis serotype 2 (SS2) is an emerging zoonosis, and meningitis is the most frequent clinical manifestation, but mechanism of its virulent factor, enolase (Eno), is unknown in meningitis. In this study, Eno was inducibly expressed and added to an in vitro Transwell co-culture model of the blood-brain barrier (BBB) consisted of porcine brain microvascular endothelial cells (PBMECs) and astrocytes (ACs), the results showed that Eno induces a significant increase in BBB permeability and promotes the release of IL-8 et al. cytokines. Furthermore, IL-8 could significantly destroy the integrity of the BBB model in vitro. In mice models administered Eno for 24 h, Eno could significantly promote Evans blue (EB) moving from the blood to the brain and significantly increased the serum and brain levels of IL-8, as detected by ELISA. While G31P (IL-8 receptor antagonist) significantly decreased the concentration of EB in the brains of mice injected with Eno. The present study demonstrated that SS2 Eno may play an important role in disrupting BBB integrity by prompting IL-8 release.Entities:
Keywords: blood–brain barrier; enolase; meningitis; streptococcus suis serotype 2
Mesh:
Substances:
Year: 2016 PMID: 26732390 DOI: 10.1007/s10753-015-0298-7
Source DB: PubMed Journal: Inflammation ISSN: 0360-3997 Impact factor: 4.092